Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery – a Qualitative Study
PCPs perceived GLP-1RAs as a promising and effective tool for addressing recurrent weight gain after MBS, and that care options for patients had improved. Systematic barriers were perceived to have a negative impact on the effectiveness of treatment. More expert guidance and support to effectively treat patients with GLP-1RAs after MBS is needed.
Authors
- Lindsey Grace
- Daniel P. Andersson (ORCID: https://orcid.org/0000-0003-4655-4837)
- Afton M. Koball (ORCID: https://orcid.org/0000-0001-9145-3061)
- Erin C. Standen (ORCID: https://orcid.org/0000-0003-3975-7038)
- Liisa Tolvanen (ORCID: https://orcid.org/0000-0002-4741-162X)
- Karin Mossberg (ORCID: https://orcid.org/0000-0001-7359-7424)
- Sean M. Phelan (ORCID: https://orcid.org/0000-0003-2091-6297)
Institutions
- Mayo Clinic (US)
- Karolinska University Hospital (SE)
- WinnMed (US)
- Karolinska Institutet (SE)
- Region Västra Götaland (SE)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Rice University (US)
- University of Gothenburg (SE)
Publication Details
- Journal
- Obesity Surgery
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1007/s11695-025-08408-0
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Karolinska Institutet